First US commercial procedures completed with Emboline’s device

Emboline completed the first two commercial US procedures using its Emboliner Embolic Protection System for transcatheter aortic valve implantation (TAVI). The device is designed to protect patients during valve replacement by capturing embolic debris. The milestone marks the system's entry into routine clinical use in the United States following regulatory clearance.